Repeat Dose Safety Study for Compound to Treat Asthma
NCT01202214 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2011-01-31
Summary
The purpose of this study is to describe the safety and tolerability of single and repeat oral doses of GSK1440115 in healthy volunteers.
Conditions
Interventions
- DRUG
-
1440115
- DRUG
-
matching placebo
Sponsors & Collaborators
-
Accenture
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
Countries
- Australia
Study Locations
More Related Trials
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
NCT01160003 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple Ascending Dose of KBL693 in Healthy Participants
NCT04307173 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation Of A New Medication (GW642444) In Asthmatic Patients
NCT00354874 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
GSK2190915 Moderate to Severe Asthma Study
NCT00850642 ·Status: TERMINATED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects
NCT01339897 ·Status: COMPLETED ·Phase: PHASE1
-
GSK2190915 Neutrophilic Asthma Study
NCT01471665 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
NCT02479412 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
NCT01316315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients
NCT00347139 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics
NCT00945932 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study in Subjects With Asthma
NCT00980200 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma
NCT03207243 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
NCT01147744 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge
NCT00445510 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00603278 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
NCT03393806 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
NCT06020014 ·Status: COMPLETED ·Phase: PHASE2
-
A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
NCT01641692 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.
NCT01425801 ·Status: COMPLETED ·Phase: PHASE2